2-N-(1-benzylpiperidin-4-yl)-6-N-[2-(4-methoxyphenyl)ethyl]-9-thiophen-3-ylpurine-2,6-diamine
C30H33N7OS — CID 117078951
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-N-(1-benzylpiperidin-4-yl)-6-N-[2-(4-methoxyphenyl)ethyl]-9-thiophen-3-ylpurine-2,6-diamine
2-N-(1-benzylpiperidin-4-yl)-6-N-[2-(4-methoxyphenyl)ethyl]-9-thiophen-3-ylpurine-2,6-diamine (PubChem CID 117078951) has the molecular formula C30H33N7OS and a molecular weight of 539.71 g/mol. Its IUPAC name is 2-N-(1-benzylpiperidin-4-yl)-6-N-[2-(4-methoxyphenyl)ethyl]-9-thiophen-3-ylpurine-2,6-diamine.
Molecular Properties
| Compound Name | 2-N-(1-benzylpiperidin-4-yl)-6-N-[2-(4-methoxyphenyl)ethyl]-9-thiophen-3-ylpurine-2,6-diamine |
|---|---|
| PubChem CID | 117078951 |
| Molecular Formula | C30H33N7OS |
| Molecular Weight | 539.71 g/mol |
| Exact Mass | 539.25 |
| IUPAC Name | 2-N-(1-benzylpiperidin-4-yl)-6-N-[2-(4-methoxyphenyl)ethyl]-9-thiophen-3-ylpurine-2,6-diamine |
| SMILES | COc1ccc(CCNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3c2ncn3-c2ccsc2)cc1 |
| InChI | InChI=1S/C30H33N7OS/c1-38-26-9-7-22(8-10-26)11-15-31-28-27-29(37(21-32-27)25-14-18-39-20-25)35-30(34-28)33-24-12-16-36(17-13-24)19-23-5-3-2-4-6-23/h2-10,14,18,20-21,24H,11-13,15-17,19H2,1H3,(H2,31,33,34,35) |
| InChIKey | WEIDUYDWIKZULI-UHFFFAOYSA-N |
| XLogP | 5.62 |
| TPSA | 80.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 539.71 |
| LogP ≤ 5 | 5.62 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 117078951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.